LinkedIn founder Reid Hoffman has been immersed in Silicon Valley since his August 1967 birth in Palo Alto, California, in the shadow of Stanford University, where he and fellow technology luminary Peter Thiel became friends as college students during the 1980s.

They went on to start PayPal during the late 1990s while working alongside a coterie of other bright-eyed entrepreneurs who went on to even bigger things, just as Hoffman did. That group ...

Schools are facing cuts across Minnesota. Bloomington has an interesting plan. LinkedIn founder Reid Hoffman has been immersed in Silicon Valley since his August 1967 birth in Palo Alto ...

LinkedIn founder Reid Hoffman has been immersed in Silicon Valley since his August 1967 birth in Palo Alto, California, in the shadow of Stanford University, where he and fellow technology ...

Reid Hoffman is a Partner at Greylock Partners and Co-Founder and Executive Chairman at LinkedIn (NYSE: LNKD). Reid joined Greylock Partners in 2009. His areas of focus include consumer Internet, enterprise 2.

LinkedIn founder Reid Hoffman has been immersed in Silicon Valley since his August 1967 birth in Palo Alto, California, in the shadow of Stanford University, where he and fellow technology

Reid Hoffman, LinkedIn founder, has been influential in Silicon Valley since 1967. He co-founded PayPal with Peter Thiel and is now worth $2.6 billion, advocating for AI's potential in his book 'Superagency,

In an interview with LinkedIn News' Jessi Hempel, the tech visionary will explain why he believes AI has the potential to reshape humanity for the better.

The author of the seminal cancer biography The Emperor Of All Maladies and the co-founder of LinkedIn are looking to connect their skills to the development of new medicines by launching a new artificial intelligence-driven drug discovery outfit.

Academics Learning at Harvard can happen for every type of learner, at any phase of life.

In Reid Hoffman’s new book Superagency: What Could Possibly Go Right With Our AI Future, the LinkedIn co-founder makes the case that AI can extend human agency — giving us more knowledge, better jobs, and improved lives — rather than reducing it.

Hoffman isn’t the only prominent Silicon Valley figure betting on A.I.’s promise in medical research. The new technology is expected to generate between $60 billion and $110 billion annually in value for the pharmaceutical and medical-product industries, according to a McKinsey report released last year.